Novartis Institutes for BioMedical Research, Inc., 10% Owner at Intellia Therapeutics, Inc. (NTLA), bought 3,356,778 shares at $18.00 ($5.0M) on 2016-05-11, disclosed to the SEC on 2016-05-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 3,079,001 | $0 | 0.0% |
| 2 | $18.00 | 277,777 | $5.0M | 100.0% |
| Total | $1.49 avg | 3,356,778 | $5.0M | 100% |
| Filing → |